Trial Profile
Add-on Study of CCBs or Diuretics in Essential Hypertension Not Achieving Target Blood Pressure on Olmesartan Medoxomil Alone.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2017
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Calcium channel antagonists; Diuretics
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 11 Mar 2009 New trial record